Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

FGFR1 Gene Amplification × AZD4547 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 3 Neoplasms 2 Carcinoma, Transitional Cell 2 Carcinoma, Non-Small-Cell Lung 2 Stomach Neoplasms 1 Recurrent Squamous Cell Lung Carcinoma 1 Non-small Cell Lung Cancer Metastatic 1 Muscle Invasive Bladder Cancer 1 Multiple Myeloma 1 Lymphoma 1 Lung Neoplasms 1 Hematologic Neoplasms 1 FGFR1 Gene Amplification 1 Carcinoma, Squamous Cell 1 Adenocarcinoma 1

Interventions

Docetaxel 1 AZD4547 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02965378 2021-05-27

Lung-MAP: AZD4547 as Second-Line Therapy in Treating FGFR Positive Patients With Recurrent Stage IV Squamous Cell Lung Cancer

SWOG Cancer Research Network

Phase 2/3 Completed

43 enrolled 15 charts

FGFR1 Gene Amplification

Data powered by HemOnc (CC BY 4.0) Colophon ⚡